CTOs on the Move

Abiomed

www.abiomed.com

 
Abiomed is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 500 employees.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.abiomed.com
  • 22 Cherry Hill Dr
    Danvers, MA USA 01923
  • Phone: 978.646.1400

Executives

Name Title Contact Details

Similar Companies

Regional MRI

Regional MRI is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cholestech Corporation

Cholestech Corporation (Cholestech) is a provider of diagnostic tools and information for immediate risk assessment and therapeutic monitoring of heart disease and diabetes. The Company manufactures and markets the LDX System in the United States and

First-Call Medical

First-Call Medical is a Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Second Sight

Second Sight ® Medical Products, Inc., located in Sylmar, California, was founded in 1998 to create a retinal prosthesis to provide sight to patients blinded from outer retinal degenerations, such as Retinitis Pigmentosa.

ApiJect

ApiJect Systems, Corp. is reimagining how injectable medicines can be packaged and delivered to the world. ApiJect`s technology platform is based on a design philosophy of basic interlocking components to create simple and highly-scalable drug delivery devices. Our first product is the ApiJect Prefilled Injector, a single-dose parenteral that is manufactured in two parts: a Blow-Fill-Seal (BFS) Container aseptically filled with medicine or vaccine, and an insulin-style Needle Hub, also made by ApiJect. At the point of care, a healthcare worker attaches these two components in seconds to activate the injector. By using high-speed, high-volume Blow-Fill-Seal plastics technology, we can reliably supply millions of aseptically filled prefilled injectors per month. Simple devices like these will enable ApiJect to fulfill its mission of making injectable medicines safe and available for everyone.